Tag: glaucoma doctor Gurgaon

OCT Normal But Vision Symptoms Persist

A normal eye scan does not always explain real-world visual symptoms. Persistent blur, reading fatigue, low-light difficulty, contrast loss, or visual discomfort may need deeper functional and clinical evaluation.

Seeing clearly on tests is not always the same as seeing comfortably in life. When symptoms persist despite normal OCT findings, the next step may be understanding how your eyes and visual system function—not just how they look, Dr Shibal Bhartiya explains.

My OCT Is Normal — So Why Does Vision Still Feel Wrong?

You came in with a symptom. You left with a normal report. And yet something is still not right.

That gap — between what tests show and what you feel — is one of the most common reasons patients seek a second opinion. It is also one of the most undertreated problems in eye care.

If your OCT is normal but your vision feels blurred, dim, or unreliable, this article explains what may be happening, what else needs to be checked, and what you should ask your doctor next.

The short answer

A normal OCT does not mean your eyes are healthy. It means the test did not detect structural damage at the time it was taken. OCT measures the thickness of retinal layers and the optic nerve fibre layer. It cannot measure how well those cells are functioning, how signals travel to the brain, or how your visual cortex processes what it receives.

Vision is not a photograph. It is a continuous biological process — and that process can fail at many points that OCT simply cannot see.

What OCT actually measures — and what it misses

OCT (Optical Coherence Tomography) creates a cross-sectional image of retinal tissue. It is excellent at detecting structural thinning, fluid, and anatomical changes.

It does not measure:

  • Nerve fibre function (only structure)
  • Signal transmission speed from eye to brain
  • Brain processing of visual information
  • Dynamic contrast sensitivity
  • Early functional loss before structural change occurs

This is the key clinical reality: functional loss can precede structural loss. A normal OCT early in the disease does not rule out damage — it rules out visible damage.

Why your vision symptoms may be real even with a normal OCT

SymptomPossible explanationTest OCT misses
Blurred vision, tests normalDry eye, early corneal irregularity, refractive instabilityCorneal topography, tear film assessment
Dim or washed-out visionContrast sensitivity loss, early optic neuropathyContrast sensitivity testing, VEP
Peripheral vision lossPre-perimetric glaucoma, neurological causeVisual field test, MRI
Fluctuating visionIntraocular pressure spikes, diabetes-related changes24-hour IOP monitoring, HbA1c
Vision worse at nightEarly rod photoreceptor dysfunction, vitamin A deficiencyERG, dark adaptometry
Double visionBinocular misalignment, cranial nerve palsyOrthoptic assessment, neuroimaging
Colour desaturationOptic neuritis, nutritional optic neuropathyColour vision testing, MRI of optic nerves

What we often miss

1. The structure-function gap in glaucoma OCT can be normal in early glaucoma. If you have a family history, high IOP, thin corneas, or disc suspicion, a normal OCT does not close the investigation. Visual field testing and longitudinal OCT comparison matter more than a single normal scan.

2. Dry eye causing real blur Tear film instability creates optical aberrations that no retinal scan captures. Patients with significant dry eye can have 20/20 Snellen acuity on a chart and genuinely blurred functional vision in daily life. This is not imagined — it is a real, measurable phenomenon on corneal topography and tear film assessment.

3. Contrast sensitivity loss Standard visual acuity testing uses high-contrast black letters on white backgrounds. Functional vision operates in low-contrast environments — faces, steps, road markings at dusk. Contrast sensitivity can be significantly reduced with a perfectly normal Snellen chart and a normal OCT. It is almost never tested in a standard eye examination.

4. Optic neuritis and demyelinating disease Early optic neuritis — inflammation of the optic nerve — can cause colour desaturation, pain on eye movement, and mild vision loss before OCT shows nerve fibre thinning. In retrobulbar neuritis, the OCT and eye examination are often normal. Just the pupils may be affected. The diagnosis is clinical and confirmed with MRI, not OCT.

5. Functional visual disturbance Some patients have genuine visual symptoms originating in the visual cortex or processing pathways rather than the eye itself. Migraine aura, cortical spreading depression, and posterior cortical atrophy all produce visual symptoms with entirely normal eye examinations. These require neurological evaluation.

6. Nutritional optic neuropathy Vitamin B12 deficiency, folate deficiency, and toxic exposures (including some medications) can produce progressive vision loss that appears structurally normal on OCT for months before thinning is detectable. Colour vision testing and a detailed history are the first clue.

The clinical principle that changes everything

In medicine, the absence of a finding on one test is not the same as the absence of disease.

OCT is one tool. It has a detection threshold. Below that threshold, it reports normal — and genuine pathology exists. Good clinical judgment means combining the test result with the symptom history, risk profile, and the full clinical picture.

A patient who says “something feels wrong” and has a normal OCT has not been cleared. They have had one test, which found nothing on that day, using that technology, at that stage of their condition.

When you should seek a second opinion

Seek a specialist review if:

  • You have persistent visual symptoms and have been told “tests are normal”
  • You have a family history of glaucoma, macular degeneration, or optic nerve disease
  • Your symptoms affect daily function — driving, reading, night vision — even if your Snellen acuity is normal
  • You have been given a diagnosis that does not fully explain your experience
  • You have systemic conditions including diabetes, hypertension, autoimmune disease, or a neurological history
  • Your symptoms are progressing, even slowly

A second opinion is not a reflection on your current doctor. It is appropriate care when symptoms persist without resolution.

What a thorough evaluation includes beyond OCT

A complete workup for unexplained vision symptoms may include some of these tests:

  • Visual field testing (perimetry) — functional, not structural
  • Contrast sensitivity testing — functional vision in real-world conditions
  • Corneal topography and tear film assessment — for optical surface irregularity
  • 24-hour IOP monitoring — for pressure spikes missed in clinic
  • Visual Evoked Potentials (VEP) — signal transmission from eye to brain
  • Electroretinogram (ERG) — photoreceptor function
  • MRI of the brain and optic nerves — when neurological cause is possible
  • Colour vision testing — early optic nerve dysfunction
  • Blood tests — B12, folate, HbA1c, autoimmune markers, thyroid function

FAQ

Can glaucoma be missed on a normal OCT?

Yes. In early glaucoma structural changes on OCT may not yet be detectable, even when functional damage has begun. This is why clinical context, risk factors, and longitudinal monitoring matter alongside any single test result.

What does it mean if my vision is blurry but my eye test is normal?

It means the standard test did not identify a cause — not that no cause exists. Dry eye, contrast sensitivity loss, early optic nerve dysfunction, and neurological causes can all produce real blur with a normal standard examination. Further testing is appropriate.

My doctor said everything is fine but I still have symptoms. What should I do?

Ask for a more detailed explanation of which tests were done and what they measure. If your symptoms persist or affect your daily life, a second specialist opinion is reasonable and appropriate.

Is a normal OCT enough to rule out glaucoma?

Not on its own. OCT is one part of a glaucoma assessment. Clinical history, intraocular pressure pattern, corneal thickness, optic disc appearance, family history, and visual field results all contribute to the complete picture. A single normal OCT in a high-risk individual does not close the diagnosis.

Can dry eye cause vision symptoms with a normal OCT?

Yes. Tear film instability creates real optical blur that OCT does not capture. If your OCT and retinal examination are normal and you have persistent blur — especially variable blur that improves on blinking — dry eye deserves careful investigation.

When does a normal eye test mean something is happening in the brain?

If your eye examination is entirely normal — including the tear film and cornea, OCT, visual fields, and optic nerve — but visual symptoms persist, neurological evaluation is appropriate. Conditions including migraine, demyelinating disease, and cortical visual processing disorders produce genuine symptoms originating beyond the eye itself.

What you can do now

If your OCT is normal but symptoms persist, write down the following before your next appointment:

  1. Exactly what you experience — blur, dimness, distortion, peripheral loss, fluctuation
  2. When it is worst — morning, evening, certain distances, particular lighting
  3. How long it has been present and whether it is changing
  4. Any systemic conditions, medications, or family history of eye disease

This history is often the most important diagnostic information available. Tests answer the questions doctors think to ask. Your symptoms tell a broader story.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Family History & Glaucoma Screening

Family History & Glaucoma Screening– My Parent or Sibling Has Glaucoma. Do I Need to Get Tested Too? Short answer, YES. Having a first degree relative with glaucoma: a parent, sibling, or child, raises your lifetime risk of developing the disease by four to nine times compared to someone with no family history, says Dr Shibal Bhartiya.

Your parent or sibling has just been diagnosed with glaucoma. Or perhaps they have had it for years and you are only now realising what that means for you.

You are asking the right question. Most people do not ask it until it is too late. Dr Shibal Bhartiya explains more.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Why Family History Changes Everything in Glaucoma

Glaucoma is not random. It runs in families. Having a first degree relative with glaucoma: a parent, sibling, or child, raises your lifetime risk of developing the disease by four to nine times compared to someone with no family history.

That is not a small increase. That is a fundamental shift in your risk category.

And yet most first degree relatives of glaucoma patients never get tested. They wait for symptoms. Glaucoma does not produce symptoms until significant, often irreversible damage has already occurred. By the time your vision changes, the window for early intervention has often narrowed considerably.

This is why family history glaucoma screening exists: not to frighten you, but to find the disease before it finds you.

What Is the First Degree Relative Glaucoma Risk?

A first degree relative is a parent, sibling, or child: someone who shares approximately 50 percent of your genetic material.

The first degree relative glaucoma risk is well established in research. Studies consistently show that having one affected first degree relative raises your risk of developing primary open angle glaucoma to approximately 1 in 5. Having two affected first degree relatives raises it further.

The risk is highest when the affected relative developed glaucoma before the age of 60, when the disease was severe at diagnosis, or when the relative required surgery rather than drops alone.

First degree relative glaucoma risk is also higher in specific ethnic groups. People of African descent carry a higher baseline risk. In India, primary angle closure glaucoma has a higher prevalence than in Western populations, and this pattern also clusters in families.

Knowing your family history is not just useful. In glaucoma, it is clinically essential.

Does Having a Family History Mean You Will Definitely Get Glaucoma?

No. A family history raises your risk. It does not guarantee disease.

Many people with a strong family history never develop glaucoma. Many develop it only in their seventies or eighties, when treatment is straightforward and vision loss is entirely preventable with monitoring.

What family history means clinically is this: you belong in a higher-risk group that benefits from earlier, more frequent screening for glaucoma. That is all. It is not a sentence. It is a schedule.

Glaucoma Risk Factors Beyond Family History

Family history is the single strongest glaucoma risk factor after age. But it does not act alone. Several other glaucoma risk factors combine with family history to raise your personal risk further.

Age is the most consistent glaucoma risk factor across all populations. Risk rises steeply after 40 and continues to increase with each decade.

Raised eye pressure, also called ocular hypertension, is a major modifiable glaucoma risk factor. Not everyone with high eye pressure develops glaucoma, but the risk is substantially elevated, particularly when combined with family history.

Myopia (near-sightedness) increases glaucoma risk, particularly for primary open angle glaucoma. Moderate to high myopia is an independent glaucoma risk factor.

Thin corneas reduce the accuracy of eye pressure measurements and are independently associated with glaucoma progression risk.

Systemic conditions including diabetes, hypertension, and migraine are associated with higher glaucoma risk in some studies, particularly for normal tension glaucoma.

Previous eye injury or steroid use — whether eye drops, inhalers, skin creams, or oral steroids — can raise eye pressure and trigger steroid-induced glaucoma, particularly in genetically susceptible individuals.

When you combine a family history of glaucoma with one or more of these additional glaucoma risk factors, the case for early screening becomes compelling.

What Does Screening for Glaucoma in Adults Actually Involve?

Screening for glaucoma in adults is not a single test. It is a short, structured examination that covers the four main parameters of glaucoma assessment.

Eye pressure measurement — intraocular pressure is measured using a non-contact tonometer or applanation tonometry. This takes less than a minute. It is painless.

Optic nerve assessment — the ophthalmologist examines the optic disc through a dilated pupil or with specialist lenses. The size, shape, and symmetry of the optic nerve head are evaluated. This is the most important part of any glaucoma screening examination.

Corneal thickness measurement — pachymetry measures corneal thickness, which affects the interpretation of eye pressure readings.

OCT imaging — optical coherence tomography of the RNFL and optic nerve head provides structural data that can detect early glaucoma damage before any symptoms or visual field changes occur. You can read more about what an OCT scan shows and how to interpret your report.

Visual field testing — in higher-risk individuals, a visual field test maps peripheral and central vision to detect any functional loss.

Gonioscopy — in patients where angle closure is suspected, gonioscopy examines the drainage angle of the eye. This is particularly relevant in Indians, where angle closure glaucoma is more prevalent.

A complete screening for glaucoma in adults takes approximately 45 to 60 minutes at a specialist glaucoma clinic, including dilation time.

When Should Screening for Glaucoma Early Begin?

The timing of screening for glaucoma early depends on your personal risk profile.

For most adults with a first degree relative with glaucoma and no other risk factors, screening should begin at 40. Some guidelines recommend starting at 35 in high-risk ethnic groups or when the affected relative had early-onset disease.

For adults with a family history plus additional glaucoma risk factors: high myopia, raised eye pressure found incidentally, or very thin corneas, earlier screening is warranted. In these cases, a baseline examination in the mid-thirties is reasonable.

For adults with no family history and no other risk factors, screening for glaucoma in adults is generally recommended from the age of 40 as part of a routine comprehensive eye examination.

The question is not whether to screen. The question is when to start and how often to repeat.

How Often Should You Be Screened?

Frequency depends on what the first examination shows.

If the first screening is entirely normal: normal eye pressure, healthy optic nerve, normal OCT, annual or biennial review is appropriate for most people in the family history risk group.

If the first screening shows borderline findings: slightly elevated pressure, a suspicious optic disc, or mildly thin RNFL on OCT, more frequent monitoring is needed. Your glaucoma specialist will advise a specific schedule based on your individual findings.

If the first screening confirms early glaucoma, you move from a screening pathway to a treatment and monitoring pathway. Early glaucoma detected through family history glaucoma screening is almost always manageable, and vision loss is highly preventable with timely intervention.

Detecting Glaucoma Early: Why It Matters So Much

Glaucoma destroys retinal nerve fibres. Once those fibres are gone, they do not regenerate. The vision lost to glaucoma does not return.

Detecting glaucoma early changes the entire trajectory of the disease. A patient diagnosed at the very beginning of structural damage, before any visual field loss, has an excellent long-term prognosis with appropriate treatment. A patient diagnosed after significant optic nerve damage faces a harder, narrower path.

The difference between these two patients is often not biology. It is timing. It is whether someone in the family said: you should get checked, and whether the person listened.

Detecting glaucoma early through structured family history screening is one of the highest-value interventions in all of preventive ophthalmology. It costs very little. It changes lives.

What Happens If Glaucoma Is Found?

Finding glaucoma early through family history glaucoma screening is not bad news. It is good news delivered at the right time.

Early glaucoma in a screened patient is almost always managed with eye drops alone. Treatment is started, eye pressure is brought to a safe target, and the optic nerve is monitored regularly. Most patients with early glaucoma, managed well and consistently, never develop significant visual impairment.

The goal of glaucoma treatment is not to cure the disease. It is to slow it so completely that it never affects your quality of life. That goal is realistic. It is achieved every day for patients who are found early.

What changes if glaucoma is found is not your life. It is your schedule, a few extra clinic visits and a bottle of eye drops. That is the trade. For preserved vision over decades, it is a very good trade.

What If the Screening Is Normal?

A normal screening result is genuinely reassuring, but it is not a permanent all-clear.

Glaucoma can develop or progress at any age. A normal result at 40 means you do not have glaucoma now. It does not mean you will never develop it. This is why regular, repeated family history glaucoma screening matters more than a single normal result.

Think of it the way you think of blood pressure checks or dental appointments. A normal result today schedules your next check. It does not cancel all future checks.

Where to Get Screened in Gurgaon

If you have a family history of glaucoma and have not yet been assessed, a structured glaucoma risk evaluation with a glaucoma specialist in Gurgaon is the right next step.

A specialist assessment goes beyond a basic eye pressure check. It includes optic nerve imaging, corneal thickness measurement, OCT analysis, and visual field testing, and if indicated, gonioscopy. This gives you a complete, documented baseline against which future examinations can be compared.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram. She offers structured glaucoma risk assessments for patients with a family history of glaucoma, including those seeking a second opinion on existing results or diagnoses.

Appointments: +91 88826 38735

Upload your reports for a structured review.

Gentle Takeaway

Your parent’s diagnosis is information. It is not fate.

The single most useful thing you can do with that information is act on it early, before symptoms, before damage, before the window narrows.

Glaucoma caught early is a very manageable disease. Glaucoma caught late is a much harder conversation. The difference is often a single timely appointment.

Book one.

Family History as a Glaucoma Risk Trigger, Not a Footnote

A positive family history remains one of the most clinically actionable risk signals in glaucoma, yet also one of the most under-leveraged.

First-degree relatives of patients with glaucoma have a substantially higher lifetime risk (often 3–4× or more), and importantly, may develop disease earlier and with more aggressive trajectories.

Dr Bhartiya’s editorial along with geneticists from AIIMS, New Delhi and Marengo Asia, emphasises on integrating genomics into practice (PMID: 41523176), reinforcing that family history is not merely a background detail but a proxy for inherited susceptibility that should actively trigger structured screening pathways.

In practical terms, this shifts glaucoma care from opportunistic detection to targeted risk-based screening, where identifying and counselling family members becomes a core extension of clinical responsibility, not an optional add-on.

Clinical Reality (Family History & Glaucoma Screening in India)

  • Family history is one of the strongest risk factors — but often ignored
    Many patients only realise its importance after damage has already occurred.
  • Screening is not routine for relatives
    Unlike diabetes or hypertension, glaucoma screening is rarely proactively advised to family members.
  • “No symptoms” delays first check
    High-risk individuals often wait for visual complaints, by which time disease may already be advanced.
  • Normal eye check-ups may miss early glaucoma
    Routine vision tests without optic nerve evaluation or fields can miss disease.
  • Younger family members are often overlooked
    Screening is delayed until later decades, despite risk beginning earlier.
  • One normal test gives false reassurance
    A single normal OCT or pressure reading does not rule out future risk.

What Good Screening Looks Like (If You Have a Family History of Glaucoma)

  • Early baseline screening — before symptoms
    Ideally by age 30–40, or earlier if multiple affected relatives.
  • Comprehensive evaluation, not just vision or pressure
    Includes optic nerve assessment, OCT, visual fields, corneal thickness.
  • Risk-stratified follow-up
    Frequency depends on baseline findings — not “come if needed.”
  • Family-based screening approach
    First-degree relatives (parents, siblings, children) are actively advised evaluation.
  • Longitudinal monitoring
    Tracking change over time is key — not single reports.
  • Clear patient education
    Understanding risk improves adherence to follow-up and screening.

Family History & Glaucoma Screening: What’s Missed vs What Matters

SituationWhat Patients Often AssumeClinical Reality (India Context)What Good Care Looks Like
Family history present“It’s not affecting me yet”Risk is significantly higher even without symptomsEarly baseline screening for all first-degree relatives
No symptoms“I’ll get checked if I notice a problem”Glaucoma remains silent until irreversible damageScreening before symptoms begin
Routine eye check-up“My eyes were checked, so I’m fine”Standard vision tests may miss early glaucomaComprehensive glaucoma evaluation (OCT + fields + nerve exam)
Age factor“I’m too young to worry”Risk can begin earlier in those with family historyScreening from 30–40 years or earlier if high risk
Single normal report“Everything was normal last time”One test cannot rule out future progressionPeriodic follow-up based on risk profile
Family awareness“No one told my family to get tested”Screening advice is often not extended to relativesProactive, family-based screening approach
Follow-up“I’ll come back if needed”Irregular follow-up delays detection of early changesStructured, risk-based follow-up intervals
Understanding risk“It’s just genetic, nothing to do now”Early detection can prevent vision lossEducation + long-term monitoring strategy
Disease perception“Glaucoma means high pressure only”Many patients develop glaucoma at normal pressuresBroader risk assessment beyond IOP
Goal of screening“Just to rule it out”Screening is about early detection and tracking changeLong-term risk management, not one-time clearance

Frequently Asked Questions: Family History and Glaucoma Screening

Does glaucoma run in families?

Yes. Having a first degree relative: a parent, sibling, or child with glaucoma raises your lifetime risk of developing the disease by four to nine times. Family history is the single strongest glaucoma risk factor after age. Structured family history glaucoma screening is recommended for all first degree relatives of glaucoma patients.

What is the risk of glaucoma if a parent has it?

The first degree relative glaucoma risk is approximately 1 in 5 for primary open angle glaucoma, significantly higher than the general population risk of around 1 in 50. The risk is higher when the affected parent developed glaucoma early, had severe disease, or required surgery.

At what age should I get screened for glaucoma if a parent has it?

Screening for glaucoma early should begin at 40 for most adults with a first degree relative with glaucoma. Those with additional glaucoma risk factors, high myopia, raised eye pressure, or thin corneas, should consider a baseline examination from the mid-thirties.

What does glaucoma screening involve?

Screening for glaucoma in adults includes eye pressure measurement, optic nerve assessment through a dilated pupil, corneal thickness measurement, OCT imaging of the nerve fibre layer, and visual field testing in higher-risk individuals. A complete specialist assessment takes approximately 45 to 60 minutes.

Can glaucoma skip a generation?

Yes. The genetic inheritance pattern of glaucoma is complex and not fully understood. Glaucoma can skip generations or manifest differently across family members. A negative family history in your parents does not fully exclude risk if grandparents or siblings are affected.

What glaucoma risk factors increase my risk beyond family history?

Key glaucoma risk factors that combine with family history include age over 40, raised eye pressure, moderate to high myopia, thin corneas, diabetes, and previous steroid use. The more risk factors present alongside family history, the stronger the case for early and frequent screening.

If my glaucoma screening is normal, do I still need follow-up?

Yes. A normal result at first screening does not mean permanent all-clear. Glaucoma can develop at any point. Annual or biennial review is recommended for adults with a family history of glaucoma, even when the initial assessment is entirely normal.

Book a consultation with Dr Shibal Bhartiya:

Marengo Asia Hospitals, Gurugram

Phone: +91 88826 38735

Website: drshibalbhartiya.com

Google Business Profile: maps.app.goo.gl/mcfegmHTuhqV5hSp6

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on Pubmed, Google Scholar, ResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

More Glaucoma Eye Drops is Not Better Glaucoma Care

More glaucoma eye drops do not guarantee better control. Treatment must be individualised based on risk, progression, and tolerance. Overmedication can increase side effects, reduce adherence, and still fail to protect long-term vision, explains Dr Shibal Bhartiya. Adding more glaucoma medications does not always mean better care and may reflect disease progression requiring proper reassessment.

When glaucoma worsens, many patients assume the next step is simple: add more eye drops.
But glaucoma care is not about the number of medicines. It is about protecting the optic nerve safely over a lifetime.

Sometimes adding drops helps. Sometimes it harms. Good care depends on judgement, sequencing, and long-term strategy.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Glaucoma Is a Long-Arc Disease

Glaucoma damage is slow, silent, and irreversible.

Treatment must balance:

The goal is not perfect numbers. The goal is lifelong, stable vision.

What Is Target Eye Pressure?

Every patient has a target intraocular pressure (IOP), a level considered safe for their optic nerve.

This depends on:

Two patients with the same pressure may need very different treatment. Glaucoma care is about staying below your safe pressure consistently, not just lowering it once.

Dr Bhartiya, along with her colleagues in Australia and Switzerland, has published peer-reviewed research on current perspectives on Target IOP in glaucoma practice, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes. Her 2014 paper, Target Intraocular Pressure: Approaches and Options, examines how glaucoma specialists should set, communicate, and revise pressure targets, balancing clinical evidence, patient preferences, and long-term vision outcomes. It is cited by glaucoma surgeons internationally and is freely available on PubMed.

When More Eye Drops Are Not Better

Adding multiple medications can lead to:

  • Redness, burning, and irritation
  • Allergy and eyelid swelling
  • Severe dryness
  • Complex dosing schedules
  • Poor adherence

In some cases, pressure appears controlled, but damage continues.

More medication does not always mean better protection.

What Is Maximal Medical Therapy?

Maximal medical therapy refers to using the maximum safe combination of eye drops before considering laser or surgery.

But “maximum” is not always “optimal.”

It can result in:

  • Ocular surface damage
  • Poor compliance
  • Fluctuating eye pressure
  • Reduced quality of life

In many cases, laser or surgery may be safer than adding more drops. Glaucoma care is not reactive, it is risk-governed.

Fixed-Dose Combination Drops: A Smarter Approach

Fixed-dose combinations combine two medications in one bottle.

They help by:

  • Reducing the number of drops
  • Simplifying treatment
  • Improving adherence
  • Lowering preservative exposure

Often, simpler regimens protect vision better than complex ones.

What Is Preservative Load?

Many glaucoma drops contain preservatives. Using multiple medications increases cumulative preservative exposure, which can damage the eye surface.

This may cause:

Reducing drops, or using preservative-free options, can significantly improve comfort and safety.

Why More Glaucoma Drops is Not Better Glaucoma Care

SituationWhat Patients Often ThinkWhat Is Actually HappeningWhat Better Care Looks Like
Pressure still high“Add another drop”Target pressure may be wrong or disease is progressing despite treatmentReassess diagnosis, stage, and target pressure
Multiple drops prescribed“More medicines = stronger treatment”Overmedication increases side effects without improving outcomesRationalise drops, simplify regimen
Eyes becoming red / irritated“Drops are working but causing minor issues”Ocular surface damage from preservatives affecting adherenceSwitch to preservative-free or reduce drop burden
Vision feels worse despite “good reports”“Tests are normal, so everything is fine”Functional loss or fluctuation not captured in routine examsCorrelate symptoms with OCT + visual fields
Frequent drop changes“Doctor is trying different combinations”Lack of structured long-term planEstablish stable, personalised treatment pathway
Difficulty remembering drops“I just need to be more careful”Complex regimens reduce compliance and effectivenessSimplify treatment or consider laser (SLT)
Long-term progression“Glaucoma just gets worse over time”Inadequate monitoring or delayed escalationTimely escalation: laser or surgery when needed

Glaucoma Care Is Not Just About Pressure

Effective glaucoma management looks beyond numbers:

  • Optic nerve structure
  • OCT trends over time
  • Visual field progression
  •  Target IOP
  • Medication tolerance
  •  Lifestyle and adherence

More treatment is not always better treatment. The right treatment, at the right time, matters more.

Clinical Reality (What’s Not Always Obvious)

  1. More drops does not mean better control
    Adding medications can feel like escalation, but without reassessing the disease, it may not improve long-term outcomes.
  2. A “good” pressure reading can be misleading
    One normal reading does not guarantee stability—glaucoma damage can continue silently between visits.
  3. Treatment can become habit instead of strategy
    Over time, care may drift into simply adding or switching drops rather than redefining targets and plans.
  4. Side effects quietly affect outcomes
    Multiple preserved drops can irritate the ocular surface, making patients less consistent with treatment.
  5. Stable reports don’t always mean stable disease
    Individual tests may look fine, but progression often appears only when data is tracked over time.
  6. Complex regimens reduce adherence
    The more complicated the schedule, the harder it becomes to follow consistently—reducing real-world effectiveness.
  7. Escalation is often delayed
    Laser or surgery may be postponed because “something is being done,” even if it’s no longer enough.
  8. Follow-up gaps change the disease trajectory
    Longer intervals without structured review can allow subtle progression to go unnoticed.
  9. Targets are not always redefined
    As glaucoma advances, the required pressure often needs to be lower—but this isn’t always updated.
  10. Activity is mistaken for effectiveness
    More visits, more drops, more changes—these can create the illusion of control without actually protecting vision.

When Laser or Surgery May Be Safer

Laser or surgery may be recommended if:

  • Target pressure is not achieved
  • Drops cause significant side effects
  • Adherence is difficult
  • Disease continues to progress
  • Risk of vision loss is high

These decisions are about long-term safety, not treatment failure.

Signs Your Glaucoma Treatment Needs Review

Consider a second opinion if you notice:

  • Increasing number of medications
  • Persistent redness or irritation
  • Confusing or difficult schedules
  • “Normal” pressure but worsening tests
  • High cost or poor affordability
  • Reduced quality of life

Treatment should feel sustainable and tolerable.

Why an Independent Glaucoma Review Helps

Glaucoma decisions are complex and long-term.

A structured second opinion can help:

  • Reconfirm diagnosis
  • Reassess target IOP
  • Simplify medications
  • Identify better options
  • Avoid overtreatment

Especially important if you are on 3 or more eye drops.

The Real Goal of Glaucoma Care

Not perfect pressure numbers. Not maximum medications.

The goal is:

  • Right treatment
  • Right timing
  • Minimal burden
  • Long-term stability

More eye drops do not always mean better care.

FAQs

1. Do more glaucoma eye drops mean better treatment?

No. More drops do not necessarily improve outcomes. Treatment must be tailored to your risk profile and disease progression, not just escalated.

2. How many glaucoma drops are too many?

There is no fixed number, but if you are on 3 or more medications, your treatment strategy should be reviewed for effectiveness, tolerance, and alternatives.

3. Why do glaucoma drops stop working?

Glaucoma may progress despite treatment, or medications may become less effective over time. Poor adherence and incorrect sequencing also play a role.

4. What are the side effects of multiple glaucoma drops?

Common side effects include redness, burning, dryness, allergy, blurred vision, and poor tolerance, especially with long-term use.

5. What is target eye pressure in glaucoma?

Target IOP is the pressure level considered safe for your optic nerve. It varies based on damage, age, and progression risk.

6. Are laser or surgery better than eye drops?

In some cases, yes. If drops are not effective or tolerated, laser or surgery may offer safer long-term control.

7. What are fixed combination glaucoma drops?

These combine two medications in one bottle, helping reduce drop burden, improve compliance, and lower preservative exposure.

8. When should I get a second opinion for glaucoma?

If you are on multiple drops, still progressing, or experiencing side effects, a second opinion can help optimise your treatment plan.

 Book a glaucoma care review

Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on Pubmed, Google Scholar, ResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Cataract Surgery Does Not Protect You From Glaucoma

Posted on by Dr Shibal Bhartiya

Cataract surgery can improve vision by removing a cloudy lens, but it does not prevent, cure, or eliminate the risk…

Services

Dr Shibal Bhartiya offers glaucoma diagnosis and treatment, second opinions, dry eye, neuro-ophthalmology, paediatric eye care, and specialist consultations at Marengo Asia Hospitals, Sector 56, Gurgaon.

She is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her focus is on identifying risk before damage becomes irreversible, simplifying treatment decisions, and protecting vision long-term. She is rated 5 stars across 1,500+ patient reviews on Google.

Glaucoma Care

Most patients who see Dr Bhartiya for glaucoma are either newly diagnosed and uncertain what to do next, or have been on treatment for years and are not sure it is working. Both are valid reasons to be here.

Specialist Consultations

These are services for patients with specific clinical questions — often patients who have been elsewhere and want a focused, expert assessment.

  • Eye evaluation before GLP-1 agonists (Ozempic, Wegovy, Mounjaro): screening for retinal and optic nerve risk before starting or continuing GLP-1 medications. Dr Bhartiya has published a systematic review on GLP-1 agonists and the eye (PubMed indexed, 2025).
  • Online glaucoma consultation and second opinion: remote consultation for glaucoma, optic nerve concerns, and complex eye conditions, for patients outside Gurgaon and Faridabad
  • Second opinion for complex eye conditions: before any eye surgery, for unexplained vision changes, or when you want clarity before committing to a treatment plan
  • Pre-surgical counselling: understanding options, risks, and benefits before cataract, glaucoma, or refractive surgery
  • Guidance for chronic eye conditions: long-term support and realistic planning for patients managing glaucoma, dry eye, or other ongoing conditions

Ocular Surface Diseases

Screen time, pollution, and contact lens use are driving a quiet epidemic of surface eye disease. Many patients have been told their eyes are “normal” when the problem is simply being missed.

Neuro-ophthalmology

Symptoms like sudden vision loss, double vision, drooping eyelid, or unexplained headache with eye pain often sit at the boundary of neurology and ophthalmology. Dr Bhartiya sees these cases directly.

Paediatric Ophthalmology

Children rarely complain about their vision — they simply adapt. A missed refractive error or lazy eye can affect learning, confidence, and development for years.

Comprehensive Eye Health

Not Sure About Your Diagnosis? You Are Not Alone.

Many patients arrive after a diagnosis elsewhere — unsure whether to start treatment, concerned about long-term progression, or wanting clarity before committing to a plan. A second opinion is not a sign of distrust. It is good medicine.

Request a Glaucoma Second Opinion →

Where to Find Us

Marengo Asia Hospitals, Gurgaon Golf Course Ext Rd, Sushant Lok II, Sector 56, Gurugram 122011 Appointments: +91 88826 38735 | 1800 309 4444 | +91 98187 00269

Teleconsultation is available for patients outside Gurgaon. Dr Bhartiya is happy to work in partnership with your local eye doctor over time.

Full contact details and directions →

Frequently Asked Questions

Do I need a referral to see Dr Bhartiya?

No. You can book directly by calling +91 88826 38735. A referral is welcome if you have one, but it is not required.

Can I get a second opinion if I already have a diagnosis elsewhere?

Yes, this is one of the most common reasons patients come. Bring any reports, scans, or prescriptions you have. You can also upload them in advance for a structured review before your appointment.

What should I bring for my first appointment?

Previous prescriptions, glasses, eye drop bottles if you use them, and any imaging or investigation reports. Full guidance is on the What to Bring page.

Is teleconsultation available?

Yes. Patients outside Gurgaon and Faridabad can consult remotely. Call +91 88826 38735 to arrange.

How long does a glaucoma evaluation take?

A comprehensive glaucoma evaluation including visual fields and imaging typically takes 1.5 to 2 hours. Please plan accordingly.

Does Dr Bhartiya see children?

Yes. Paediatric eye exams, squint, amblyopia, and myopia control are part of regular practice.

I am on Ozempic or a GLP-1 medication. Should I get my eyes checked?

Yes. Emerging research links GLP-1 agonists with retinal and optic nerve changes in some patients. Dr Bhartiya offers a dedicated pre- and on-treatment eye evaluation. Read the published research

About Dr Shibal Bhartiya

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term.

She is Clinical Director of Ophthalmology at Marengo Asia Hospitals, Gurugram, Editor-in-Chief of Clinical and Experimental Vision and Eye Research, and Executive Editor of the Journal of Current Glaucoma Practice, PubMed-indexed, official journal of the International Society of Glaucoma Surgery.

Her 200+ publications, including 90+ PubMed-indexed papers and 28 edited textbooks, span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Her work is accessible on PubMed, Google Scholar, ResearchGate, and ORCID.

Full doctor profile → Patient testimonials → Leave a Google review → Upload your reports for a structured review →

Second Opinion | Teleconsultation Online

For patients who live elsewhere, Dr Bhartiya is happy to work in partnership with your local eye doctor to guide and support your care over time.